Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $687.86 million. The enterprise value is $664.93 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 126.91 million shares outstanding. The number of shares has decreased by -3.51% in one year.
| Current Share Class | 126.91M |
| Shares Outstanding | 126.91M |
| Shares Change (YoY) | -3.51% |
| Shares Change (QoQ) | +3.14% |
| Owned by Insiders (%) | 38.02% |
| Owned by Institutions (%) | 46.22% |
| Float | 55.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.81 |
| PS Ratio | 1.48 |
| Forward PS | 1.11 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 3.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.43 |
| EV / EBITDA | 34.00 |
| EV / EBIT | 483.58 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.32 |
| Quick Ratio | 2.57 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.05 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.30% and return on invested capital (ROIC) is 0.21%.
| Return on Equity (ROE) | 0.30% |
| Return on Assets (ROA) | 0.18% |
| Return on Invested Capital (ROIC) | 0.21% |
| Return on Capital Employed (ROCE) | 0.33% |
| Revenue Per Employee | $535,349 |
| Profits Per Employee | -$10,616 |
| Employee Count | 869 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.56 |
Taxes
| Income Tax | -7.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.16% in the last 52 weeks. The beta is 1.49, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +34.16% |
| 50-Day Moving Average | 4.65 |
| 200-Day Moving Average | 4.35 |
| Relative Strength Index (RSI) | 54.93 |
| Average Volume (20 Days) | 3,139,388 |
Short Selling Information
The latest short interest is 10.65 million, so 8.39% of the outstanding shares have been sold short.
| Short Interest | 10.65M |
| Short Previous Month | 11.11M |
| Short % of Shares Out | 8.39% |
| Short % of Float | 19.22% |
| Short Ratio (days to cover) | 16.78 |
Income Statement
In the last 12 months, ORGO had revenue of $465.22 million and -$9.23 million in losses. Loss per share was -$0.08.
| Revenue | 465.22M |
| Gross Profit | 346.56M |
| Operating Income | 1.38M |
| Pretax Income | -6.20M |
| Net Income | -9.23M |
| EBITDA | 19.56M |
| EBIT | 1.38M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $63.75 million in cash and $40.81 million in debt, giving a net cash position of $22.94 million or $0.18 per share.
| Cash & Cash Equivalents | 63.75M |
| Total Debt | 40.81M |
| Net Cash | 22.94M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 385.98M |
| Book Value Per Share | 2.01 |
| Working Capital | 209.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.79 million and capital expenditures -$12.86 million, giving a free cash flow of -$51.65 million.
| Operating Cash Flow | -38.79M |
| Capital Expenditures | -12.86M |
| Free Cash Flow | -51.65M |
| FCF Per Share | -$0.41 |
Full Cash Flow StatementMargins
Gross margin is 74.49%, with operating and profit margins of 0.30% and 0.22%.
| Gross Margin | 74.49% |
| Operating Margin | 0.30% |
| Pretax Margin | -1.33% |
| Profit Margin | 0.22% |
| EBITDA Margin | 4.20% |
| EBIT Margin | 0.30% |
| FCF Margin | n/a |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.51% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.34% |
| FCF Yield | -7.51% |
Analyst Forecast
The average price target for ORGO is $8.00, which is 47.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 47.60% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.73 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.73 |
| Piotroski F-Score | 2 |
